Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
Summary
GBI Research has released its Chemical research, “Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth”. The report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, product type analysis, drivers and restraints, analysis of the therapeutic categories and a market share analysis of the major producers in the important geographical markets of the world. In addition, it includes market forecasts, product type analysis and therapeutic categories analysis of the APIs in major countries of the world. Overall, the report presents a comprehensive analysis of the global API market covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
North America and Europe together account for more than 60% share in the global API market revenue. Asia-Pacific is the fastest growing API market in the world. The global API demand is led by China, India and Brazil. The innovator APIs are increasingly losing market share to generic sector APIs. On the basis of synthesis route, the synthetic APIs continue to dominate the global revenues. However, the growth in biotech APIs is expected to be faster in the forecast period.
The global API sales revenue was $91 billion in 2009 and is expected to grow at a CAGR of 5.9% from 2010 to 2015. The growth will be driven by the rise in demand of generic sector drugs and biological drugs. The recovery from economic slowdown will help the global API market to grow. The global API sales revenue is expected to reach $126.3 billion in 2015.
Scope
GBI Research has released its Chemical research, “Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth”. The report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, product type analysis, drivers and restraints, analysis of the therapeutic categories and a market share analysis of the major producers in the important geographical markets of the world. In addition, it includes market forecasts, product type analysis and therapeutic categories analysis of the APIs in major countries of the world. Overall, the report presents a comprehensive analysis of the global API market covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
North America and Europe together account for more than 60% share in the global API market revenue. Asia-Pacific is the fastest growing API market in the world. The global API demand is led by China, India and Brazil. The innovator APIs are increasingly losing market share to generic sector APIs. On the basis of synthesis route, the synthetic APIs continue to dominate the global revenues. However, the growth in biotech APIs is expected to be faster in the forecast period.
The global API sales revenue was $91 billion in 2009 and is expected to grow at a CAGR of 5.9% from 2010 to 2015. The growth will be driven by the rise in demand of generic sector drugs and biological drugs. The recovery from economic slowdown will help the global API market to grow. The global API sales revenue is expected to reach $126.3 billion in 2015.
Scope
- Market revenue data for APIs from 2005 to 2009 and forecast for six years to 2015.
- API markets in key regions: North America, Europe, Asia-Pacific and South and Central America.
- API markets in key countries: the US, Canada, Germany, the UK, France, Italy, Spain, Japan, China, India, Mexico and Brazil.
- Drivers of the API market such as growth in generic drugs and biotech drugs, and restraints such as economic slowdown and patent expiries, for the global market as well as for regional markets.
- Information on the competitive landscape with the shares of leading companies such as Pfizer Inc, AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Sanofi Aventis and Novartis.
- Analysis of API revenue by product type in the global market, in key regions and countries
- Analysis of API revenue by therapeutic category in the key countries.
- Develop business strategies by understanding the trends and developments that are driving the global APIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the APIs market.
- Identify macro and micro-economic trends shaping and driving the global APIs market.
Contents
1 TABLE OF CONTENTS1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION
2.1 GBI Report Coverage
3 GLOBAL API MARKET
3.1 Global API Industry Structure
3.2 Global API Industry Challenges
3.2.1 Maturity of the Market in Developed Regions Restricts the Global API Revenue Growth
3.2.2 High Cost of New Drug Development Becomes a Hurdle to Innovation
3.2.3 Highly Fragmented Nature of Market Leads to Intense Competition and Price Decline
3.2.4 Regulatory Challenges Delay the Launch of Drugs
3.3 Global API Market Overview
3.4 Global API Market Revenue Analysis and Forecasts to 2015
3.5 Global API Market Revenue Share Analysis by Product Type and Forecasts to 2015
3.5.1 Global API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015
3.5.2 Global API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
3.6 Global API Revenue Share Analysis by Region and Forecasts to 2015
3.7 Global API Market Competitive Landscape
4 NORTH AMERICA API MARKET
4.1 North America API Market Overview
4.2 North America API Market Drivers
4.2.1 Growth in the Generic Sector is Leading the Overall Growth in Demand for APIs in the Region
4.2.2 Increasing Focus on Biological Drugs Contributes to the Growth of API Demand in the Region
4.2.3 The Rising Incidence of Lifestyle and Older Age Diseases is Giving Rise to API Demand in the Region
4.2.4 Growth in Oncology is one of the Major Contributing Factors to the Growth of APIs in the Region
4.2.5 Increasing Focus on High Potency APIs Helps the Market Growth
4.3 North America API Market Restraints
4.3.1 The Economic Downturn has Restricted the Growth of API Demand in the Region
4.3.2 Decreasing Focus on the Innovator Sector Limits the Growth of North American API Market
4.3.3 Patent Expiry of Some Blockbuster Molecules Will Adversly Affect the Growth of API Market in the Region
4.3.4 Rising Competition from China and India is Creating Price Pressure in the North American Market
4.4 North America API Market Revenue Analysis and Forecasts to 2015
4.5 North America API Market Revenue Share Analysis by Product Type and Forecasts to 2015
4.5.1 North America API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015
4.5.2 North America API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
4.6 North America API Market Revenue Share Analysis by Country and Forecasts to 2015
4.7 North America API Market Competitive Landscape
4.8 The US API Market
4.8.1 The US API Market Overview
4.8.2 The US API Market Revenue Analysis and Forecasts to 2015
4.8.3 The US API Market Revenue Share Analysis by Product Type and Forecasts to 2015
4.8.4 The US API Market Revenue Share Analysis by Therapeutic Category
4.9 Canada API Market
4.9.1 Canada API Market Overview
4.9.2 Canada API Market Revenue Analysis and Forecasts to 2015
4.9.3 Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2015
4.9.4 Canada API Market Revenue Share Analysis by Therapeutic Category
5 EUROPE API MARKET
5.1 Europe API Market Overview
5.2 Europe API Market Drivers
5.2.1 Rising Demand in the Generic Sector Forces the API Market to Grow in the Region
5.2.2 Increasing Focus on Biopharmaceuticals Encourages the Growth in the API Market
5.2.3 Rising Incidences of Lifestyle Diseases and Older Age Diseases in the Region Enable the Growth in API Market
5.2.4 Growth in Oncology Contributes to the API Market growth in the Region
5.2.5 Increasing Focus on HPAPI Helps the Overall API Revenue Growth
5.2.6 Increasing Number of Development Projects in Therapeutic Peptide Area
5.3 Europe API Market Restraints
5.3.1 The Economic Slowdown is Hampering the Overall Pharmaceutical Market in the Region
5.3.2 Large Number of Patent Expiries Will Lead to Reduced Growth in the Region’s API Market
5.3.3 Decreasing Focus on Innovator Drug Sector Restricts the Overall API Market Revenue
5.3.4 Price Erosion in the API Market is Hindering the Revenue Growth
5.4 Europe API Market Revenue Analysis and Forecasts to 2015
5.5 Europe API Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.5.1 Europe API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015
5.5.2 Europe API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
5.6 Europe API Market Revenue Share Analysis by Country and Forecasts to 2015
5.7 Europe API Market Competitive Landscape
5.8 Germany API Market
5.8.1 Germany API Market Overview
5.8.2 Germany API Market Revenue Analysis and Forecasts to 2015
5.8.3 Germany API Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.8.4 Germany API Market Revenue Share Analysis by Therapeutic Category
5.9 The UK, API Market
5.9.1 The UK, API Market, Overview
5.9.2 The UK API Market Revenue Analysis and Forecasts to 2015
5.9.3 The UK API Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.9.4 The UK API Market Revenue Share Analysis by Therapeutic Category
5.10 France API Market
5.10.1 France API Market Overview
5.10.2 France API Market Revenue Analysis and Forecasts to 2015
5.10.3 France Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.10.4 France API Market Revenue Share Analysis by Therapeutic Category
5.11 Italy API Market
5.11.1 Italy API Market Overview
5.11.2 Italy API Market Revenue Analysis and Forecasts to 2015
5.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.11.4 Italy API Market Revenue Share Analysis by Therapeutic Category
5.12 Spain API Market
5.12.1 Spain API Market Overview
5.12.2 Spain API Market Revenue Analysis and Forecasts to 2015
5.12.3 Spain API Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.12.4 Spain API Market Revenue Share Analysis by Therapeutic Category
6 ASIA-PACIFIC API MARKET
6.1 Asia-Pacific API Market Overview
6.2 Asia-Pacific API Market Drivers
6.2.1 Rapidly Growing Economies of China and India Favour the Growth in the Region’s API Market Revenue
6.2.2 The Booming Generic Drug Sector is Leading the Growth of API Market in Asia Pacific
6.2.3 Increasing Demand of Innovator Drugs Contributes to the Revenue Growth in the Region’s API Market
6.2.4 Growth in the Development of Biotech Drugs Helps API Market Revenue to Grow in the Region
6.2.5 Peptide APIs Offer Growth Opportunities to the Asia-Pacific’s API Market
6.2.6 Government’s Plan to Develop Multi-level Insurance System in China is Set to Boost the Growth of the API Market
6.3 Asia-Pacific API Market Restraints
6.3.1 Rising Competition is Leading to Price Erosion Which Affects the Revenue Growth in the API Market of the Region
6.3.2 Fluctuations in the Prices Acts as a Hurdle in the Revenue Growth
6.3.3 Surplus Capacity May Emerge as a Challenge for Producers in China and India
6.3.4 The Global Economic Slowdown has Reduced the Demand in the API Market
6.4 Asia-Pacific API Market Revenue Analysis and Forecasts to 2015
6.5 Asia-Pacific API Market Revenue Share Analysis by Product Type and Forecasts to 2015
6.5.1 Asia-Pacific, API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015
6.5.2 Asia-Pacific API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
6.6 Asia-Pacific API Market Revenue Share Analysis by Country and Forecasts to 2015
6.7 Asia-Pacific API Market Competitive Landscape
6.8 Japan API Market
6.8.1 Japan API Market Overview
6.8.2 Japan API Market Revenue Analysis and Forecasts to 2015
6.8.3 Japan API Market Revenue Share Analysis by Product Type and Forecasts to 2015
6.8.4 Japan API Market Revenue Share Analysis by Therapeutic Category
6.9 China API Market
6.9.1 China API Market Overview
6.9.2 China API Market Revenue Analysis and Forecasts to 2015
6.9.3 China API Market Revenue Share Analysis by Product Type and Forecasts to 2015
6.9.4 China API Market Revenue Share Analysis by Therapeutic Category
6.10 India API Market
6.10.1 India API Market Overview
6.10.2 India API Market Revenue Analysis and Forecasts to 2015
6.10.3 India API Market Revenue Share Analysis by Product Type and Forecasts to 2015
6.10.4 India API Market Revenue Share Analysis by Therapeutic Category
7 SOUTH AND CENTRAL AMERICA API MARKET
7.1 South and Central America API Market Overview
7.2 South and Central America API Market Drivers
7.2.1 Rapidly Growing Brazilian Economy Boosts the Overall API Market Growth in the Region
7.2.2 Growth in the Generic Sector Augments the Overall API Market Growth
7.2.3 Growth in Biotechnology Adds Significantly to the Growth of API Market in the Region
7.2.4 Increasing Ageing Population, Changing Demographics and Lifestyle Helps Growth in the API Market of the Region
7.3 South and Central America API Market Restraints
7.3.1 Economic Slowdown has Hampered the Growth of Pharmaceutical Market in the Region
7.3.2 The Slowdown in the Innovator Drugs Market in the Region has Affected the Overall API Market Growth
7.3.3 Declining Prices Restricts the Revenue Growth of the API Market in the Region
7.4 South and Central America API Market Revenue Analysis and Forecasts to 2015
7.5 South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2015
7.5.1 South and Central America API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015
7.5.2 South and Central America API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
7.6 South and Central America API Market Revenue by Country and Forecasts to 2015
7.7 South and Central America API Market Competitive Landscape
7.8 Mexico API Market
7.8.1 Mexico API Market Overview
7.8.2 Mexico API Market Revenue Analysis and Forecasts to 2015
7.8.3 Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2015
7.8.4 Mexico API Market Revenue Share Analysis by Therapeutic Category
7.9 Brazil API Market
7.9.1 Brazil API Market Overview
7.9.2 Brazil API Market Revenue Analysis and Forecasts to 2015
7.9.3 Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2015
7.9.4 Brazil API Market Revenue Share Analysis by Therapeutic Category
8 APPENDIX
8.1 Market Definitions
8.2 Abbreviations
8.3 Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Primary Research
8.3.4 Expert Panel Validation
8.4 Contact Us
8.5 About GBI Research
8.6 Disclaimer
LIST OF TABLES
Table 1: API Market, Global, Revenues, $m, 2005–2015
Table 2: API Market, Global, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 3: API Market, Global, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 4: API Market, Global, Revenue Share Analysis by Region, %, 2009–2015
Table 5: API Market, Global, Revenue Share Analysis by Company, 2009
Table 6: API Market, North America, Revenues, $m, 2005–2015
Table 7: API Market, North America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 8: API Market, North America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 9: API Market, North America, Revenue Share Analysis by Country, %, 2009 and 2015
Table 10: API Market, North America, Revenue Share Analysis by Company, 2009
Table 11: API Market, The US, Revenues, $m, 2005–2015
Table 12: API Market, The US, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 13: API Market, The US, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 14: API Market, The US, Revenue Shares by Therapeutic Category, %, 2009
Table 15: API Market, Canada, Revenues, $m, 2005–2015
Table 16: API Market, Canada, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 17: API Market, Canada, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 18: API Market, Canada, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 19: API Market, Europe, Revenues, $m, 2005–2015
Table 20: API Market, Europe, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 21: API Market, Europe, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009–2015
Table 22: API Market, Europe, Revenue Share Analysis by Country, %, $m, 2009–2015
Table 23: API Market, Europe, Revenue Share Analysis by Company, %, 2009
Table 24: API Market, Germany, Revenues, $m, 2005–2015
Table 25: API Market, Germany, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 26: API Market, Germany, Revenue Share Analysis by Product Type Based on Generic Sector, %, 2009 and 2015
Table 27: API Market, Germany, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 28: API Market, The UK, Revenues, $m, 2005–2015
Table 29: API Market, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 30: API Market, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 31: API Market, The UK, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 32: API Market, France, Revenues, $m, 2005–2015
Table 33: API Market, France, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 34: API Market, France, Revenue Share Analysis by Product Type Based on Innovator and Generic Sector, %, 2009 and 2015
Table 35: API Market, France, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 36: API Market, Italy, Revenues, $m, 2005–2015
Table 37: API Market, Italy, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 38: API Market, Italy, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 39: API Market, Italy, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 40: API Market, Spain, Revenues, $m, 2005–2015
Table 41: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector Spanish, %, 2009 and 2015
Table 42: API Market, Revenue Share Analysis by Product Type Based on Innovator and Generic sector APIs in the Spanish, %, 2009 and 2015
Table 43: API Market, Spain, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 44: API Market, Asia-Pacific, Revenues, $m, 2005–2015
Table 45: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 46: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 47: API Market, Asia-Pacific, Revenue Share Analysis by Country, %, 2009 and 2015
Table 48: API Market, Japan, Revenues, $m, 2005–2015
Table 49: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 50: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 51: API Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2009
Table 52: API Market, China, Revenues, $m, 2005–2015
Table 53: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 54: API Market, China, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 55: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 56: API Market, India, Revenues, $m, 2005–2015
Table 57: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 58: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 59: API Market, India, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 60: API Market, South and Central America, Revenues, $m, 2005–2015
Table 61: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 62: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009–2015
Table 63: API Market, South and Central America, Revenue Share Analysis by Country, %, 2009–2015
Table 64: API Market, Mexico, Revenues, $m, 2005–2015
Table 65: API Market, Mexico, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 66: API Market, Mexico, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 67: API Market, Mexico, Revenue Share Analysis by Therapeutic Category, %, 2009
Table 68: API Market, Brazil, Revenues, $m, 2005–2015
Table 69: API Market, Brazil, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Table 70: API Market, Brazil, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Table 71: API Market, Brazil, Revenue Share Analysis by Therapeutic Category, %, 2009
LIST OF FIGURES
Figure 1: API, Global, Industry Value Chain, 2009
Figure 2: API Market, Global, Revenues, $m, 2005–2015
Figure 3: API Market, Global, Product Type, 2009
Figure 4: API Market, Global, Revenue Share Analysis by Synthesis Route, %, 2009 and 2015
Figure 5: API Market, Global, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 6: API Market, Global, Revenue Share Analysis by Region, %, 2009 and 2015
Figure 7: API Market, Global, Revenue by Share Analysis by Company, 2009
Figure 8: API Market, North America, Revenues, $m, 2005–2015
Figure 9: API Market, North America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 10: API Market, North America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 11: API Market, North America, Revenue Share Analysis by Country, %, 2009 and 2015
Figure 12: API Market, North America, Revenue Share Analysis by Company, 2009
Figure 13: API Market, The US, Revenues, $m, 2005–2015
Figure 14: API Market, The US, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 15: API Market, The US, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 16: API Market, The US, Revenue Shares by Therapeutic Category, %, 2009
Figure 17: API Market, Canada, Revenues, $m, 2005–2015
Figure 18: API Market, Canada, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 19: API Market, Canada, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 20: API Market, Canada, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 21: API Market, Europe, Revenues, $m, 2005–2015
Figure 22: API Market, Europe, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 23: API Market, Europe, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 24: API Market, Europe, Revenue Share Analysis by Country, %, 2009 and 2015
Figure 25: API Market, Europe, Revenue Share Analysis by Company, %, 2009
Figure 26: API Market, Germany, Revenues, $m, 2005–2015
Figure 27: API Market, Germany, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 28: API Market, Germany, Revenue Share Analysis by Product Type Based on Generic Sector, %, 2009 and 2015
Figure 29: API Market, Germany, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 30: API Market, The UK, Revenues, $m, 2005–2015
Figure 31: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector, %, 2009 and 2015
Figure 32: API Market, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 33: API Market, The UK, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 34: API Market, France, Revenues, $m, 2005–2015
Figure 35: API Market, France, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 36: API Market, France, Revenue Share Analysis by Product Type Based on Innovator and Generic Sector, %, 2009 and 2015
Figure 37: API Market, France, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 38: API Market, Italy, Revenues, $m, 2005–2015
Figure 39: API Market, Italy, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 40: API Market, Italy, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 41: API Market, Italy, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 42: API Market, Spain, Revenues, $m, 2005–2015
Figure 43: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector Spanish, %, 2009 and 2015
Figure 44: API Market, Revenue Share Analysis by Product Type Based on Innovator and Generic sector APIs in the Spanish, %, 2009 and 2015
Figure 45: API Market, Spain, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 46: API Market, Asia-Pacific, Revenues, $m, 2005–2015
Figure 47: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 48: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 49: API Market, Asia-Pacific, Revenue Share Analysis by Country, %, 2009 and 2015
Figure 50: API Market, Japan, Revenues, $m, 2005–2015
Figure 51: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 52: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 53: API Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2009
Figure 54: API Market, China, Revenues, $m, 2005–2015
Figure 55: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 56: API Market, China, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 57: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 58: API Market, India, Revenues, $m, 2005–2015
Figure 59: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 60: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 61: API Market, India, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 62: API Market, South and Central America, Revenues, $m, 2005–2015
Figure 63: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 64: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 65: API Market, South and Central America, Revenue Share Analysis by Country, %, 2009–2015
Figure 66: API Market, Mexico, Revenues, $m, 2005–2015
Figure 67: API Market, Mexico, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 68: API Market, Mexico, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 69: API Market, Mexico, Revenue Share Analysis by Therapeutic Category, %, 2009
Figure 70: API Market, Brazil, Revenues, $m, 2005–2015
Figure 71: API Market, Brazil, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015
Figure 72: API Market, Brazil, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015
Figure 73: API Market, Brazil, Revenue Share Analysis by Therapeutic Category, %, 2009 Skip to top